Unknown NA INTERVENTIONAL 2-arm NCT03819946

Improving Oesophageal Protection During AF Ablation (IMPACT)

Oesophageal Protection: a Novel Approach to Improving the Safety of Catheter Ablation for Atrial Fibrillation.

Sponsor: Attune Medical

Interventions Standard esophageal temperature probe esophageal cooling device (Attune Medical, Chicago, IL)

Updated 7 times since 2019 Last updated: Dec 30, 2019 Started: Feb 1, 2019 Primary completion: Feb 1, 2020 Completion: Feb 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Esophageal Diseases, this trial is ongoing. The trial is conducted by Attune Medical and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Jan 2022 [monthly]

Recruiting NA
Feb 2020 — Jan 2021 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Oct 2019 — Feb 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2019 — Oct 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Attune Medical
St. George's Hospital, London

Data source: St. George's Hospital, London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom